{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:01:02Z","timestamp":1785391262973,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Congenital dyserythropoietic anemia type IV (CDA IV) is a rare inherited erythroid disorder within the broad phenotypic spectrum associated with pathogenic variants in Kr\u00fcppel-like factor 1 (\n                    <jats:italic>KLF1<\/jats:italic>\n                    ), a master transcriptional regulator of erythropoiesis. This study aimed to describe the clinical picture, genetic causes, global distribution, and treatment of CDA IV. We retrospectively reviewed three pediatric patients diagnosed and treated at the Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, since December 2014. Demographic, clinical, genetic, laboratory, treatment, transplantation, and follow-up data were collected, including conditioning regimens, graft-versus-host disease (GVHD) prophylaxis, engraftment, complications, and donor chimerism. We also conducted a literature review of CDA IV cases reported worldwide between January 1991 and December 2024. All three children developed symptoms within the first month of life. They had neonatal jaundice and anemia. One of them needed intrauterine transfusion. Gene testing found four\n                    <jats:italic>KLF1<\/jats:italic>\n                    variants: c.525_526insCGGCGCC, c.1012C\u2009&amp;gt;\u2009T, c.1012C\u2009&amp;gt;\u2009A, and c.973G\u2009&amp;gt;\u2009A. Before hematopoietic stem cell transplantation (HSCT), all three patients needed regular red blood cell transfusions and had iron overload. All three then received HSCT from a parent or sibling. Neutrophils and platelets engrafted in every case. Donor chimerism stayed above 95% during follow-up, and no graft failure happened. No patient had acute or chronic GVHD. Viral reactivation after HSCT was mainly cytomegalovirus (CMV) and Epstein\u2013Barr virus (EBV) infection, and no severe infection was seen. At the last follow-up, all three patients were free of transfusion. Serum ferritin levels went down after HSCT, but liver or heart iron overload did not fully go away in some patients. For carefully chosen children with severe transfusion-dependent\n                    <jats:italic>KLF1<\/jats:italic>\n                    -related red cell disease, allogeneic HSCT may be a feasible curative option. Stable donor chimerism and lasting freedom from transfusion can be achieved. CDA IV has many clinical forms and can be mistaken for thalassemia or Evans syndrome, so early gene testing is very important for correct diagnosis. In areas where thalassemia is common,\n                    <jats:italic>KLF1<\/jats:italic>\n                    mutation screening should be considered when the cause of microcytic anemia is unclear. Bigger studies with longer follow-up are still needed to better judge the long-term results of HSCT.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1854766","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:10Z","timestamp":1785389950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["KLF1 mutation-associated congenital dyserythropoietic anemia type IV: a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Kailin","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Guangxi Key Laboratory of Thalassemia Research","place":["Nanning, Guangxi, China"]},{"name":"Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences","place":["Nanning, Guangxi, China"]},{"name":"NHC Key Laboratory of Thalassemia Medicine","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Nong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Guangxi Key Laboratory of Thalassemia Research","place":["Nanning, Guangxi, China"]},{"name":"Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences","place":["Nanning, Guangxi, China"]},{"name":"NHC Key Laboratory of Thalassemia Medicine","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Guangxi Key Laboratory of Thalassemia Research","place":["Nanning, Guangxi, China"]},{"name":"Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences","place":["Nanning, Guangxi, China"]},{"name":"NHC Key Laboratory of Thalassemia Medicine","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1097\/mph.0000000000001727","article-title":"A very rare congenital dyserythropoietic anemia variant-type IV in a patient with a novel mutation in the KLF1 gene: a case report and review of the literature","volume":"42","author":"Belgemen-Ozer","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/moh.0000000000000697","article-title":"The congenital dyserythropoieitic anemias: genetics and pathophysiology","volume":"29","author":"King","year":"2022","journal-title":"Curr Opin Hematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1182\/blood.2019000948","article-title":"Congenital dyserythropoietic anemias","volume":"136","author":"Iolascon","year":"2020","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MOH.0b013e32834521b0","article-title":"Congenital dyserythropoietic anemias","volume":"18","author":"Iolascon","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ejhg.2014.291","article-title":"Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin","volume":"23","author":"Huang","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00277-020-04319-5","article-title":"Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene","volume":"100","author":"M\u00e9ndez","year":"2021","journal-title":"Ann Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/17474086.2016.1131608","article-title":"Diagnosis and management of congenital dyserythropoietic anemias","volume":"9","author":"Gambale","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood.2022018735","article-title":"A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype","volume":"141","author":"Ferrer-Vicens","year":"2023","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1182\/blood-2014-03-561779","article-title":"KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of \u03b2-thalassemia","volume":"124","author":"Liu","year":"2014","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1111\/ijlh.12788","article-title":"A KLF1 gene mutation causes \u03b2-thalassemia minor in a Chinese family","volume":"40","author":"Huang","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ajhg.2010.10.010","article-title":"A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia","volume":"87","author":"Arnaud","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcmd.2013.02.006","article-title":"Erythroid transcription factor EKLF\/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm","volume":"51","author":"Jaffray","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1182\/bloodadvances.2016002303","article-title":"KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A\/LRF in erythroid cells","volume":"1","author":"Norton","year":"2017","journal-title":"Blood Adv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jgm.2928","article-title":"Genetic disruption of the KLF1 gene to overexpress the \u03b3-globin gene using the CRISPR\/Cas9 system","volume":"18","author":"Shariati","year":"2016","journal-title":"J Gene Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin","volume":"42","author":"Borg","year":"2010","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.ygeno.2018.11.032","article-title":"Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders","volume":"111","author":"Hariharan","year":"2019","journal-title":"Genomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00277-012-1625-9","article-title":"Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin","volume":"92","author":"Radmilovic","year":"2013","journal-title":"Ann Hematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/humupd\/dms002","article-title":"Aetiology of hypospadias: a systematic review of genes and environment","volume":"18","author":"Van Der Zanden","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/humu.22218","article-title":"Molecular analysis of the rare in(lu) blood type: toward decoding the phenotypic outcome of haploinsufficiency for the transcription factor KLF1","volume":"34","author":"Helias","year":"2013","journal-title":"Hum Mutat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2187155","DOI":"10.1080\/16078454.2023.2187155","article-title":"Whole exome sequencing and rare variant association study to identify genetic modifiers, KLF1 mutations, and a novel double mutation in Thai patients with hemoglobin E\/beta-thalassemia","volume":"28","author":"Hantaweepant","year":"2023","journal-title":"Hematology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/03630269.2013.805304","article-title":"KLF1 gene mutations in Chinese adults with increased fetal hemoglobin","volume":"37","author":"Wang","year":"2013","journal-title":"Hemoglobin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/03630269.2015.1008702","article-title":"A new Kr\u00fcppel-like factor 1 mutation (c.947G>A or p.C316Y) in humans causes \u03b2-thalassemia minor","volume":"39","author":"Nitta","year":"2015","journal-title":"Hemoglobin"},{"key":"B23","doi-asserted-by":"publisher","first-page":"691461","DOI":"10.3389\/fgene.2021.691461","article-title":"Compound heterozygosity for KLF1 mutations causing hemolytic anemia in children: a case report and literature review","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3324\/haematol.2010.037333","article-title":"Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin","volume":"96","author":"Satta","year":"2011","journal-title":"Haematologica"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1182\/blood-2013-09-526087","article-title":"Mutations in Kr\u00fcppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression","volume":"123","author":"Viprakasit","year":"2014","journal-title":"Blood"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1854766\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:12Z","timestamp":1785389952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1854766\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":25,"alternative-id":["10.3389\/fped.2026.1854766"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1854766","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1854766"}}